Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Get Free Trial
Send Info
On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:18
04/18/24
04/18
11:18
04/18/24
11:18
ITCI

Intra-Cellular

$73.15 /

-3.52 (-4.59%)

, SNGX

Soligenix

/

+

, MRNS

Marinus Pharmaceuticals

$1.47 /

+0.03 (+2.08%)

, BHVN

Biohaven

$41.68 /

-2.37 (-5.38%)

, JAGX

Jaguar Health

/

+

, NCNA

NuCana

$4.05 /

-0.1 (-2.41%)

, CRBP

Corbus Pharmaceuticals

$37.26 /

-0.095 (-0.25%)

, NTLA

Intellia Therapeutics

$21.80 /

+0.29 (+1.35%)

These names in the…

Open Full Text

Over a week ago
On The Fly
Yum! downgraded, Cava upgraded: Wall Street's top analyst calls » 09:43
04/10/24
04/10
09:43
04/10/24
09:43
CAVA

Cava Group

$60.27 /

+ (+0.00%)

, VC

Visteon

$114.03 /

+ (+0.00%)

, GDRX

GoodRx

$6.75 /

+ (+0.00%)

, IONS

Ionis Pharmaceuticals

$42.86 /

+ (+0.00%)

, ALNY

Alnylam

$155.94 /

+ (+0.00%)

, CNI

Canadian National

$131.03 /

+ (+0.00%)

, YUM

Yum! Brands

$137.05 /

+ (+0.00%)

, DECK

Deckers Outdoor

$867.84 /

+ (+0.00%)

, MNDY

Monday.com

$215.70 /

+ (+0.00%)

, HXL

Hexcel

$71.14 /

+ (+0.00%)

, BA

Boeing

$178.13 /

+ (+0.00%)

, ADNT

Adient

$31.80 /

+ (+0.00%)

, FND

Floor & Decor

$122.73 /

+ (+0.00%)

, ZION

Zions Bancorp

$43.53 /

+ (+0.00%)

, ALC

Alcon

$82.69 /

+ (+0.00%)

, MKTX

MarketAxess

$226.51 /

+ (+0.00%)

, HIMS

Hims & Hers

$14.56 /

+ (+0.00%)

The most talked about and…

Open Full Text

Upgrade
Ionis Pharmaceuticals upgraded to Outperform at Wolfe Research » 17:38
04/09/24
04/09
17:38
04/09/24
17:38
IONS

Ionis Pharmaceuticals

$42.86 /

+0.62 (+1.47%)

Wolfe Research upgraded…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Upgrade
Ionis upgraded to Outperform from Peer Perform at Wolfe Research » 16:39
04/09/24
04/09
16:39
04/09/24
16:39
IONS

Ionis Pharmaceuticals

$42.86 /

+0.62 (+1.47%)

Wolfe Research upgraded…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Ionis Pharmaceuticals price target raised by $3 at Oppenheimer, here's why » 07:24
04/09/24
04/09
07:24
04/09/24
07:24
IONS

Ionis Pharmaceuticals

$42.24 /

-0.97 (-2.24%)

Oppenheimer raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Ionis Pharmaceuticals presents results from Phase 3 Balance study olezarsen » 16:04
04/07/24
04/07
16:04
04/07/24
16:04
IONS

Ionis Pharmaceuticals

$43.21 /

+0.39 (+0.91%)

Ionis Pharmaceuticals…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Ionis Pharmaceuticals management to meet with Piper Sandler » 05:55
04/03/24
04/03
05:55
04/03/24
05:55
IONS

Ionis Pharmaceuticals

$42.97 /

-0.99 (-2.25%)

Meetings to be held in…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Ionis Pharmaceuticals management to meet with Piper Sandler » 04:55
04/02/24
04/02
04:55
04/02/24
04:55
IONS

Ionis Pharmaceuticals

$43.96 /

+0.62 (+1.43%)

Meetings to be held in…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Ionis Pharmaceuticals management to meet with Piper Sandler » 10:40
03/28/24
03/28
10:40
03/28/24
10:40
IONS

Ionis Pharmaceuticals

$44.45 /

-0.215 (-0.48%)

Meetings to be held in…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Ionis Pharmaceuticals to present data from Phase 3 on olezarsen » 08:28
03/25/24
03/25
08:28
03/25/24
08:28
IONS

Ionis Pharmaceuticals

$42.71 /

-0.02 (-0.05%)

Ionis Pharmaceuticals…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a month ago
Hot Stocks
Intellia Therapeutics announces first patient dosed in Phase 3 MAGNITUDE study » 07:38
03/18/24
03/18
07:38
03/18/24
07:38
NTLA

Intellia Therapeutics

$28.30 /

+0.8 (+2.91%)

Intellia Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Ionis announces results from Phase 2 study of ION224 » 07:10
03/13/24
03/13
07:10
03/13/24
07:10
IONS

Ionis Pharmaceuticals

$43.17 /

-0.095 (-0.22%)

Ionis Pharmaceuticals…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Ionis Pharmaceuticals price target raised by $7 at Oppenheimer, here's why » 08:17
03/06/24
03/06
08:17
03/06/24
08:17
IONS

Ionis Pharmaceuticals

$44.17 /

-0.71 (-1.58%)

, RPRX

Royalty Pharma

$29.45 /

-0.43 (-1.44%)

Oppenheimer raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Ionis Pharma names Kyle Jenne new Chief Global Product Strategy Officer » 09:11
02/29/24
02/29
09:11
02/29/24
09:11
IONS

Ionis Pharmaceuticals

$46.50 /

-0.94 (-1.98%)

Ionis Pharmaceuticals…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Downgrade
Intellia Therapeutics just downgraded at Goldman Sachs, here's why » 09:18
02/23/24
02/23
09:18
02/23/24
09:18
NTLA

Intellia Therapeutics

$27.17 /

+0.33 (+1.23%)

Goldman Sachs analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Intellia Therapeutics price target lowered by $14 at Guggenheim, here's why » 08:47
02/23/24
02/23
08:47
02/23/24
08:47
NTLA

Intellia Therapeutics

$27.17 /

+0.33 (+1.23%)

Guggenheim analyst Debjit…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Intellia Therapeutics price target raised by $1 at Canaccord, here's why » 07:22
02/23/24
02/23
07:22
02/23/24
07:22
NTLA

Intellia Therapeutics

$27.17 /

+0.33 (+1.23%)

Canaccord raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Ionis Pharmaceuticals price target raised by $1 at Piper Sandler, here's why » 08:11
02/22/24
02/22
08:11
02/22/24
08:11
IONS

Ionis Pharmaceuticals

$43.57 /

-0.82 (-1.85%)

Piper Sandler raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Intellia Therapeutics reports Q4 EPS ($1.46), consensus ($1.45) » 07:35
02/22/24
02/22
07:35
02/22/24
07:35
NTLA

Intellia Therapeutics

$26.84 /

-0.34 (-1.25%)

"We're off to a…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Ionis Pharmaceuticals sees FY24 revenue over $575M, consensus $636.36M » 07:05
02/21/24
02/21
07:05
02/21/24
07:05
IONS

Ionis Pharmaceuticals

$44.39 /

-0.03 (-0.07%)

Sees FY24 operating loss…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Ionis Pharmaceuticals reports Q4 EPS (6c), consensus (83c) » 07:03
02/21/24
02/21
07:03
02/21/24
07:03
IONS

Ionis Pharmaceuticals

$44.39 /

-0.03 (-0.07%)

Reports Q4 revenue $325M,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Intellia Therapeutics price target lowered by $14 at Baird, here's why » 07:14
02/16/24
02/16
07:14
02/16/24
07:14
NTLA

Intellia Therapeutics

$28.44 /

+0.16 (+0.57%)

, ALNY

Alnylam

$147.48 /

-16.66 (-10.15%)

Baird lowered the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Intellia Therapeutics, ReCode Therapeutics to develop genomic medicines for CF » 07:43
02/15/24
02/15
07:43
02/15/24
07:43
NTLA

Intellia Therapeutics

$28.28 /

+1.825 (+6.90%)

Intellia Therapeutics and…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Intellia Therapeutics, ReCode Therapeutics announce collaboration » 07:36
02/15/24
02/15
07:36
02/15/24
07:36
NTLA

Intellia Therapeutics

$28.28 /

+1.825 (+6.90%)

Intellia Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Ionis Pharmaceuticals confirms FDA orphan designation for olezarsen » 07:15
02/15/24
02/15
07:15
02/15/24
07:15
IONS

Ionis Pharmaceuticals

$49.11 /

+0.49 (+1.01%)

Ionis Pharmaceuticals…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Intellia Therapeutics initiated with neutral view at Wolfe Research, here's why » 19:23
02/14/24
02/14
19:23
02/14/24
19:23
NTLA

Intellia Therapeutics

$28.28 /

+1.825 (+6.90%)

Wolfe Research initiated…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Ionis Pharmaceuticals initiated with neutral view at Wolfe Research, here's why » 19:19
02/14/24
02/14
19:19
02/14/24
19:19
IONS

Ionis Pharmaceuticals

$49.11 /

+0.49 (+1.01%)

Wolfe Research initiated…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Ionis Pharmaceuticals' olezarsen granted FDA orphan designation » 18:00
02/14/24
02/14
18:00
02/14/24
18:00
IONS

Ionis Pharmaceuticals

$49.11 /

+0.49 (+1.01%)

According to a post on…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Ionis Pharmaceuticals initiated with neutral view at Wolfe Research » 16:17
02/14/24
02/14
16:17
02/14/24
16:17
IONS

Ionis Pharmaceuticals

$49.11 /

+0.49 (+1.01%)

Wolfe Research initiated…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Intellia Therapeutics initiated with neutral view at Wolfe Research » 16:16
02/14/24
02/14
16:16
02/14/24
16:16
NTLA

Intellia Therapeutics

$28.28 /

+1.825 (+6.90%)

Wolfe Research initiated…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.